Sars‐Cov‐2 in a Patient with Acute Chorea: Innocent Bystander or Unexpected Actor?
Sign Up to like & getrecommendations! Published in 2021 at "Movement Disorders Clinical Practice"
DOI: 10.1002/mdc3.13274
Abstract: Chorea mostly presents as a slow-course neurodegenerative disorder with a genetic cause (Huntington’s disease). However, subacute-onset forms often have an organic (eg, vascular, infectious, paraneoplastic) or metabolic etiology. Here we provide a brief report, with… read more here.
Keywords: chorea innocent; cov patient; acute chorea; chorea ... See more keywords
Antiphospholipid‐Related Chorea: Two Case Reports and Role of Metabolic Imaging
Sign Up to like & getrecommendations! Published in 2022 at "Movement Disorders Clinical Practice"
DOI: 10.1002/mdc3.13432
Abstract: Antiphospholipid syndrome (APS) is a complex acquired autoimmune disease with a wide clinical spectrum. Chorea is a rare neurological manifestation of APS. read more here.
Keywords: case reports; antiphospholipid related; related chorea; two case ... See more keywords
Chorea as a Post‐COVID‐19 Complication
Sign Up to like & getrecommendations! Published in 2022 at "Movement Disorders Clinical Practice"
DOI: 10.1002/mdc3.13557
Abstract: Severe acute respiratory syndrome (SARS) coronavirus (COV)-2 causes flu-like symptoms, including fever, cough, fatigue, and loss of sense of smell. Although many complications of this unprecedented virus have been specified, there is still a lack… read more here.
Keywords: covid infection; history; post covid; chorea ... See more keywords
Chorea Associated with JAK2V617F ‐Positive Essential Thrombocythemia
Sign Up to like & getrecommendations! Published in 2022 at "Movement Disorders Clinical Practice"
DOI: 10.1002/mdc3.13567
Abstract: It is with great interest that we read the article by Kutty and colleagues on chorea in patients with JAK2-mutated essential thrombocythemia (ET). As pointed out by the authors, the occurrence of chorea has rarely… read more here.
Keywords: essential thrombocythemia; chorea associated; case; chorea ... See more keywords
A PDE10A de novo mutation causes childhood‐onset chorea with diurnal fluctuations
Sign Up to like & getrecommendations! Published in 2017 at "Movement Disorders"
DOI: 10.1002/mds.27175
Abstract: Recently, de novo and bi-allelic mutations in PDE10A, encoding a cyclic nucleotide phosphodiesterase selectively expressed in striatal medium spiny neurons, have been recognized as a cause of childhood-onset chorea. Brain MRI consistently showed striking bilateral… read more here.
Keywords: diurnal fluctuations; onset chorea; chorea; mri ... See more keywords
George Huntington (1850–1916)
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Neurology"
DOI: 10.1007/s00415-018-8860-5
Abstract: To the memory of Magdalena P. and all my patients with Huntington’s disease that I was unable to help as I wished. The nineteenth century was a time when specializations evolved from general medicine. General… read more here.
Keywords: medicine; huntington; george huntington; disease ... See more keywords
Intravenous immunoglobulins as first-line therapy for IgLON5 encephalopathy
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Neurology"
DOI: 10.1007/s00415-019-09221-3
Abstract: A 56-year-old man presented with a 6 month history of dysarthrophonia, orofacial dyskinesia and chorea of both hands. His wife reported snoring, day sleepiness, insomnia and limb movements during sleep. The patient and his wife… read more here.
Keywords: iglon5 encephalopathy; iglon5; treatment; impairment ... See more keywords
Deutetrabenazine: A Review in Chorea Associated with Huntington’s Disease
Sign Up to like & getrecommendations! Published in 2017 at "Drugs"
DOI: 10.1007/s40265-017-0831-0
Abstract: Oral deutetrabenazine (Austedo™), a reversible inhibitor of vesicular monoamine transporter type 2 (VMAT2) that is structurally related to tetrabenazine is approved for the treatment of chorea symptoms associated with Huntington’s disease (HD). In the pivotal… read more here.
Keywords: tetrabenazine; associated huntington; huntington disease; deutetrabenazine ... See more keywords
Successful rituximab therapy for pediatric antiphospholipid-related chorea: a case report and review of the literature.
Sign Up to like & getrecommendations! Published in 2022 at "Neuropediatrics"
DOI: 10.1055/a-1819-1883
Abstract: Chorea is considered a non-thrombotic manifestation of the antiphospholipid syndrome, often preceding thrombotic events in children. It can be present in up to 5% of pediatric patients with antiphospholipid syndrome. Immunomodulatory treatment regimens seem to… read more here.
Keywords: related chorea; therapy; case; literature ... See more keywords
Non paraneoplastic immune-mediated calcium channel chorea
Sign Up to like & getrecommendations! Published in 2019 at "Baylor University Medical Center Proceedings"
DOI: 10.1080/08998280.2019.1581318
Abstract: Abstract Antibodies to the N-type voltage-gated calcium channel have rarely been reported in association with chorea. Prior reported cases have been either paraneoplastic in nature or presented in the setting of other concurrent antibody elevations.… read more here.
Keywords: calcium channel; paraneoplastic immune; mediated calcium; immune mediated ... See more keywords
Deutetrabenazine for the treatment of Huntington’s chorea
Sign Up to like & getrecommendations! Published in 2018 at "Expert Review of Neurotherapeutics"
DOI: 10.1080/14737175.2018.1500178
Abstract: ABSTRACT Introduction: Huntington’s disease (HD) is an inherited neurodegenerative disorder for which no disease-modifying treatment is currently available. Only symptomatic treatment can be offered. Chorea is the most common motor manifestation of HD and may… read more here.
Keywords: treatment; huntington; deutetrabenazine treatment; chorea ... See more keywords